Disulfide bond structures of IgG molecules

The disulfide bond structures established decades ago for immunoglobulins have been challenged by findings from extensive characterization of recombinant and human monoclonal IgG antibodies. Non-classical disulfide bond structure was first identified in IgG4 and later in IgG2 antibodies. Although, cysteine residues should be in the disulfide bonded states, free sulfhydryls have been detected in all subclasses of IgG antibodies. In addition, disulfide bonds are susceptible to chemical modifications, which can further generate structural variants such as IgG antibodies with trisulfide bond or thioether linkages. Trisulfide bond formation has also been observed for IgG of all subclasses. Degradation of disulfide bond through β-elimination generates free sulfhydryls disulfide and dehydroalanine. Further reaction between free sulfhydryl and dehydroalanine leads to the formation of a non-reducible cross-linked species. Hydrolysis of the dehydroalanine residue contributes substantially to antibody hinge region fragmentation. The effect of these disulfide bond variations on antibody structure, stability and biological function are discussed in this review.

[1]  D. E. Olins,et al.  RECONSTITUTION OF 7S MOLECULES FROM L AND H POLYPEPTIDE CHAINS OF ANTIBODIES AND GAMMA-GLOBULINS. , 1964 .

[2]  G. Christian,et al.  THE ROLE OF DISULFIDE BONDS IN THE COMPLEMENT-FIXING AND PRECIPITATING PROPERTIES OF 7S RABBIT AND SHEEP ANTIBODIES , 1964, The Journal of experimental medicine.

[3]  The disulphide bridges of immunoglobulin kappa-chains. , 1966, The Biochemical journal.

[4]  C. Milstein.  The disulphide bridges of immunoglobulin ϰ-chains , 1966 .

[5]  C. Milstein,et al.  Inter Heavy–Light Chain Disulphide Bridge in Immune Globulins , 1967, Nature.

[6]  C. Milstein,et al.  Disulphide Bridges of a Human Immunoglobulin G Protein , 1967, Nature.

[7]  C. Milstein,et al.  Disulphide Bridges of Immunoglobin G1 Heavy Chains , 1967, Nature.

[8]  C. Milstein,et al.  Intrachain disulphide bridges in immunoglobulin G heavy chains. The Fc fragment. , 1968, The Biochemical journal.

[9]  C. Milstein,et al.  Variations in the S—S bridges of immunoglobins G: Interchain disulphide bridges of γG3 myeloma proteins , 1968 .

[10]  Variations in the S-S bridges of immunoglobins G: interchain disulfide bridges of gamma G3 myeloma proteins. , 1968, Journal of molecular biology.

[11]  Gerald M. Edelman,et al.  THE COVALENT STRUCTURE OF AN ENTIRE γG IMMUNOGLOBULIN MOLECULE , 1969 .

[12]  C. Milstein,et al.  Structural studies of immunoglobulin G. , 1969, Nature.

[13]  C. Milstein,et al.  Immunoglobulins: Structural Studies of Immunoglobulin G , 1969, Nature.

[14]  G. Edelman,et al.  The covalent structure of an entire gammaG immunoglobulin molecule. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Tanford,et al.  Recovery of native conformation of rabbit immunoglobulin G upon recombination of separately renatured heavy and light chains at near-neutral pH. , 1971, Biochemistry.

[16]  B. Smith,et al.  Conformational changes accompanying the dissociation and association of immunoglobulin-G subunits. , 1972, Biochimica et biophysica acta.

[17]  K. J. Dorrington,et al.  An in vitro system for studying the kinetics of interchain disulfide bond formation in immunoglobulin G. , 1974, The Journal of biological chemistry.

[18]  D. Isenman,et al.  The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement. , 1975, Journal of immunology.

[19]  E. Press.  Fixation of the first component of complement by immune complexes: effect of reduction and fragmentation of antibody. , 1975, The Biochemical journal.

[20]  J. Natvig,et al.  Structural Requirements in the Fc Region of Rabbit IgG Antibodies Necessary to Induce Cytotoxicity by Human Lymphocytes , 1975, Scandinavian journal of immunology.

[21]  Structure and function of immunoglobulin domains. V. Binding, University of immunoglobulin G and fragments to placental membrane preparations. , 1976, Journal of immunology.

[22]  K. J. Dorrington,et al.  Structure and Function of Immunoglobulin Domains V. Binding of Immunoglobulin G and Fragments to Placental Membrane Preparations , 1976 .

[23]  J. Whitaker,et al.  Effects of alkali on proteins. Disulfides and their products. , 1977, Journal of agricultural and food chemistry.

[24]  V. Schumaker,et al.  The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex. , 1977, Journal of immunology.

[25]  L. Chan,et al.  The role of the inter-heavy chain disulfide bond in modulating the flexibility of immunoglobulin G antibody. , 1977, Journal of molecular biology.

[26]  W. Fridman,et al.  Binding site of human IgG subclasses and their domains for Fc receptors of activated murine T cells. , 1977, Journal of immunology.

[27]  K. J. Dorrington,et al.  Structure and function of immunoglobulin domains. VII. Studies on the structural requirements of human immunoglobulin G for granulocyte binding. , 1978, Journal of immunology.

[28]  R. Poljak,et al.  Three-dimensional structure of immunoglobulins. , 1979, Annual review of biochemistry.

[29]  Y. Goto,et al.  The role of the intrachain disulfide bond in the conformation and stability of the constant fragment of the immunoglobulin light chain. , 1979, Journal of biochemistry.

[30]  V. Schumaker,et al.  Changes in quaternary structure of IgG upon reduction of the interheavy-chain disulfide bond. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Florence.  Degradation of protein disulphide bonds in dilute alkali. , 1980, The Biochemical journal.

[32]  B. A. Johnson,et al.  Effect of reduction and alkylation on structure and function of rabbit IgG antibody-I. Effect on ability to activate complement depends on conditions of reduction. , 1981, Molecular immunology.

[33]  S. Sorger,et al.  Free thiol groups and labile disulfide bonds in the IgG fraction of human serum. , 1982, Journal of immunological methods.

[34]  D. Burton.  Immunoglobulin G: functional sites. , 1985, Molecular immunology.

[35]  Labile disulfide bonds and free thiol groups in human IgG. I. Assignment to IgG1 and IgG2 subclasses. , 1986, International archives of allergy and applied immunology.

[36]  Labile disulfide bonds and free thiol groups in human IgG. II. Characteristic changes in malignant diseases corresponding to shifts of IgG1 and IgG2 subclasses. , 1986, International archives of allergy and applied immunology.

[37]  R. Aalberse,et al.  Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. , 1986, Journal of immunology.

[38]  Y. Goto,et al.  Reduction of the buried intrachain disulfide bond of the constant fragment of the immunoglobulin light chain: global unfolding under physiological conditions. , 1986, Biochemistry.

[39]  S. Rudikoff,et al.  Functional antibody lacking a variable-region disulfide bridge. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Michaelsen.  Alteration of the conformation of human IgG subclasses by reduction of the hinge S-S bonds. , 1988, Molecular immunology.

[41]  J. Schlom,et al.  Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. , 1989, Cancer research.

[42]  M. Bodmer,et al.  Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment. , 1992, The Biochemical journal.

[43]  T. Michaelsen,et al.  Human IgG3 is decreased and IgG1, IgG2 and IgG4 are unchanged in molecular size by mild reduction and reoxidation without any major change in effector functions. , 1993, Molecular immunology.

[44]  A. Lawson,et al.  A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. , 1993, Molecular immunology.

[45]  M. Madanat,et al.  Intrachain disulfide bond in the core hinge region of human IgG4 , 1997, Protein science : a publication of the Protein Society.

[46]  A. Plückthun,et al.  A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding. , 1997, Journal of molecular biology.

[47]  R. Van Ree,et al.  Normal human immunoglobulin G4 is bispecific: it has two different antigen‐combining sites , 1999, Immunology.

[48]  J. Buchner,et al.  Folding and association of the antibody domain CH3: prolyl isomerization preceeds dimerization. , 1999, Journal of molecular biology.

[49]  R. Aalberse,et al.  The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds. , 2001, Molecular immunology.

[50]  Wei Zhang,et al.  Free Sulfhydryl in Recombinant Monoclonal Antibodies , 2002, Biotechnology progress.

[51]  V. Giudicelli,et al.  IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. , 2003, Developmental and comparative immunology.

[52]  Sherie L. Morrison,et al.  Human IgG2 Can Form Covalent Dimers1 , 2003, The Journal of Immunology.

[53]  J. Trent,et al.  Understanding base-assisted desulfurization using a variety of disulfide-bridged peptides. , 2003, Biopolymers.

[54]  Mathieu Rouard,et al.  IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. , 2005, Developmental and comparative immunology.

[55]  Ziping Wei,et al.  Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains. , 2005, Analytical chemistry.

[56]  R J Harris,et al.  Heterogeneity of recombinant antibodies: linking structure to function. , 2005, Developments in biologicals.

[57]  Reed J. Harris,et al.  Effect of Copper Sulfate on Performance of a Serum‐Free CHO Cell Culture Process and the Level of Free Thiol in the Recombinant Antibody Expressed , 2008, Biotechnology progress.

[58]  D. Brems,et al.  Active dimer of Epratuzumab provides insight into the complex nature of an antibody aggregate. , 2006, Journal of pharmaceutical sciences.

[59]  N. M. Gevondyan,et al.  Four free cysteine residues found in human IgG1 of healthy donors , 2006, Biochemistry (Moscow).

[60]  P. Parren,et al.  Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange , 2007, Science.

[61]  Hongcheng Liu,et al.  Characterization of lower molecular weight artifact bands of recombinant monoclonal IgG1 antibodies on non-reducing SDS-PAGE , 2007, Biotechnology Letters.

[62]  Steven L. Cohen,et al.  Beta-elimination and peptide bond hydrolysis: two distinct mechanisms of human IgG1 hinge fragmentation upon storage. , 2007, Journal of the American Chemical Society.

[63]  E. Lacy,et al.  Free sulfhydryl measurement as an indicator of antibody stability. , 2008, Analytical biochemistry.

[64]  Thomas M. Dillon,et al.  Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass* , 2008, Journal of Biological Chemistry.

[65]  Douglas S Rehder,et al.  Structural and Functional Characterization of Disulfide Isoforms of the Human IgG 2 Subclass * , 2008 .

[66]  Thomas M. Dillon,et al.  Human IgG2 Antibody Disulfide Rearrangement in Vivo* , 2008, Journal of Biological Chemistry.

[67]  Ming Li,et al.  Human IgG2 Antibodies Display Disulfide-mediated Structural Isoforms* , 2008, Journal of Biological Chemistry.

[68]  Alain Balland,et al.  Disulfide connectivity of human immunoglobulin G2 structural isoforms. , 2008, Biochemistry.

[69]  M. Matsumura,et al.  Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain , 2007, Protein science : a publication of the Protein Society.

[70]  Steven L. Cohen,et al.  Evidence for trisulfide bonds in a recombinant variant of a human IgG2 monoclonal antibody. , 2009, Analytical chemistry.

[71]  Identification and localization of unpaired cysteine residues in monoclonal antibodies by fluorescence labeling and mass spectrometry. , 2009, Analytical chemistry.

[72]  Hongcheng Liu,et al.  Localization and quantitation of free sulfhydryl in recombinant monoclonal antibodies by differential labeling with 12C and 13C iodoacetic acid and LC-MS analysis. , 2009, Analytical chemistry.

[73]  M. Matsumura,et al.  Elucidation of two major aggregation pathways in an IgG2 antibody. , 2009, Journal of pharmaceutical sciences.

[74]  Yatin R. Gokarn,et al.  Characterization of antibody aggregation: role of buried, unpaired cysteines in particle formation. , 2010, Journal of pharmaceutical sciences.

[75]  Heather Franey,et al.  Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates , 2010, Protein science : a publication of the Protein Society.

[76]  D. Ouellette,et al.  Studies in serum support rapid formation of disulfide bond between unpaired cysteine residues in the VH domain of an immunoglobulin G1 molecule. , 2010, Analytical biochemistry.

[77]  Hongcheng Liu,et al.  Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC-MS analysis. , 2010, Analytical chemistry.

[78]  Rashmi Kshirsagar,et al.  Characterization of trisulfide modification in antibodies. , 2010, Analytical biochemistry.

[79]  J. Winther,et al.  Trisulfides in proteins. , 2011, Antioxidants & redox signaling.

[80]  Sandeep Kumar,et al.  Disulfide Scrambling in IgG2 Monoclonal Antibodies: Insights from Molecular Dynamics Simulations , 2011, Pharmaceutical Research.